These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7720818)

  • 1. Effects of transferrin receptor antibody-NGF conjugate on young and aged septal transplants in oculo.
    Bäckman C; Biddle PT; Ebendal T; Friden PM; Gerhardt GA; Henry MA; Mackerlova L; Söderström S; Strömberg I; Walus L
    Exp Neurol; 1995 Mar; 132(1):1-15. PubMed ID: 7720818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants.
    Granholm AC; Bäckman C; Bloom F; Ebendal T; Gerhardt GA; Hoffer B; Mackerlova L; Olson L; Söderström S; Walus LR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):448-59. PubMed ID: 8301587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier mediated delivery of NGF: alterations in basal forebrain neurons in aged rats revealed using antibodies against low and high affinity NGF receptors.
    Bäckman C; Rose GM; Bartus RT; Hoffer BJ; Mufson EJ; Granholm AC
    J Comp Neurol; 1997 Oct; 387(1):1-11. PubMed ID: 9331167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGF treatment promotes development of basal forebrain tissue grafts in the anterior chamber of the eye.
    Eriksdotter-Nilsson M; Skirboll S; Ebendal T; Hersh L; Grassi J; Massoulié J; Olson L
    Exp Brain Res; 1989; 74(1):89-98. PubMed ID: 2924843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease.
    Kordower JH; Charles V; Bayer R; Bartus RT; Putney S; Walus LR; Friden PM
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9077-80. PubMed ID: 8090772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review.
    Granholm AC; Albeck D; Bäckman C; Curtis M; Ebendal T; Friden P; Henry M; Hoffer B; Kordower J; Rose GM; Söderström S; Bartus RT
    Rev Neurosci; 1998; 9(1):31-55. PubMed ID: 9683326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cholinergic pedunculopontine neurons in vitro: comparison with cholinergic septal cells and response to nerve growth factor, ciliary neuronotrophic factor, and retinoic acid.
    Knusel B; Hefti F
    J Neurosci Res; 1988; 21(2-4):365-75. PubMed ID: 3216429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute application of NGF increases the firing rate of aged rat basal forebrain neurons.
    Albeck DS; Bäckman C; Veng L; Friden P; Rose GM; Granholm A
    Eur J Neurosci; 1999 Jul; 11(7):2291-304. PubMed ID: 10383618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy.
    Bäckman C; Rose GM; Hoffer BJ; Henry MA; Bartus RT; Friden P; Granholm AC
    J Neurosci; 1996 Sep; 16(17):5437-42. PubMed ID: 8757256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.
    Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL
    Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal rats.
    Hatanaka H; Tsukui H; Nihonmatsu I
    Brain Res; 1988 Mar; 467(1):85-95. PubMed ID: 3359332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion.
    Rossner S; Yu J; Pizzo D; Werrbach-Perez K; Schliebs R; Bigl V; Perez-Polo JR
    J Neurosci Res; 1996 Jul; 45(1):40-56. PubMed ID: 8811511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier penetration and in vivo activity of an NGF conjugate.
    Friden PM; Walus LR; Watson P; Doctrow SR; Kozarich JW; Bäckman C; Bergman H; Hoffer B; Bloom F; Granholm AC
    Science; 1993 Jan; 259(5093):373-7. PubMed ID: 8420006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro.
    Hartikka J; Hefti F
    J Neurosci Res; 1988; 21(2-4):352-64. PubMed ID: 3216428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate.
    Charles V; Mufson EJ; Friden PM; Bartus RT; Kordower JH
    Brain Res; 1996 Jul; 728(2):193-203. PubMed ID: 8864482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons.
    Mufson EJ; Bothwell M; Hersh LB; Kordower JH
    J Comp Neurol; 1989 Jul; 285(2):196-217. PubMed ID: 2547849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term changes in brain cholinergic markers and nerve growth factor levels after partial immunolesion.
    Gu Z; Yu J; Perez-Polo JR
    Brain Res; 1998 Aug; 801(1-2):190-7. PubMed ID: 9729378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct influences of nerve growth factor and a central cholinergic trophic factor on medial septal explants.
    Bostwick JR; Appel SH; Perez-Polo JR
    Brain Res; 1987 Sep; 422(1):92-8. PubMed ID: 3676784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons.
    Mufson EJ; Presley LN; Kordower JH
    Brain Res; 1991 Jan; 539(1):19-30. PubMed ID: 1849779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of a single nerve growth factor administration following septal damage in rats.
    Pallage V; Knusel B; Hefti F; Will B
    Eur J Neurosci; 1993 Jun; 5(6):669-79. PubMed ID: 7903189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.